Correlation between the antilipolytic and hypoglycemic actions of some salicylate structural congeners in normal and alloxan-diabetic rats.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001565:Benzoates / Q000494:pharmacology; D001786:Blood Glucose / Q000096:biosynthesis; D003374:Coumarins / Q000494:pharmacology; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D005230:Fatty Acids, Nonesterified / Q000037:antagonists & inhibitors / Q000097:blood*; D005663:Furans / Q000494:pharmacology; D007004:Hypoglycemic Agents / Q000494:pharmacology; D000960:Hypolipidemic Agents / Q000494:pharmacology; D050356:Lipid Metabolism; D009539:Nicotinic Acids / Q000494:pharmacology*; D011392:Proline / Q000494:pharmacology; D051381:Rats; D012459:Salicylates / Q000494:pharmacology*; D013876:Thiophenes / Q000494:pharmacology; D062367:ortho-Aminobenzoates / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D001565:Benzoates; D001786:Blood Glucose; D003374:Coumarins; D005230:Fatty Acids, Nonesterified; D005663:Furans; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents; D009539:Nicotinic Acids; D012459:Salicylates; D013876:Thiophenes; D062367:ortho-Aminobenzoates; D011392:Proline